Director Mary T Szela sold $967K of Coherus Oncology, Inc.

Sold$966,759

$17.58Price

54,997Shares

−100%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Mon, Jun 22. Filed Wed, Jun 24, 12:55 PM ET, during the session. Not investment advice.